1630086-20-2 (Amgen IRE1α Inhibitor,Kira8)

Kira8;Ire-1 inhibitor;Amgen IRE1alpha Inhibitor;BDBM50043766;(S)-2-Chloro-N-(6-methyl-5-((3-(2-(piperidin-3-ylamino)pyrimidin-4-yl)pyridin-2-yl)oxy)naphthalen-1-yl)benzenesulfonamide;2-chloro-N-(6-methyl-5-{[3-(2-{[(3S)-piperidin-3-yl]amino}pyrimidin-4-yl)pyridin-2-yl]oxy}naphthalen-1-yl)benzene-1-sulfonamide;QFV;2-chloro-N-[6-methyl-5-[3-[2-[[(3S)-piperidin-3-yl]amino]pyrimidin-4-yl]pyridi;AMG-18;1630086-20-2;2-chloro-N-[6-methyl-5-[3-[2-[[(3S)-piperidin-3-yl]amino]pyrimidin-4-yl]pyridin-2-yl]oxynaphthalen-1-yl]benzenesulfonamide;DTXSID901019271;BS-50674;AmgenIRE1alphaInhibitor;AKOS027328494;MFCD28404657;HY-114368;Kira8?;GLXC-20546;CS-0084229;CHEMBL3356009;DA-64749;2-chloro-N-{6-methyl-5-[(3-{2-[(3S)-piperidin-3-ylamino]pyrimidin-4-yl}pyridin-2-yl)oxy]naphthalen-1-yl}benzenesulfonamide;SCHEMBL24449081;

MFCD28404657

XMWUCMFVDXDRDE-NRFANRHFSA-N

1S/C31H29ClN6O3S/c1-20-13-14-22-23(8-4-11-27(22)38-42(39,40)28-12-3-2-10-25(28)32)29(20)41-30-24(9-6-17-34-30)26-15-18-35-31(37-26)36-21-7-5-16-33-19-21/h2-4,6,8-15,17-18,21,33,38H,5,7,16,19H2,1H3,(H,35,36,37)/t21-/m0/s1

ClC1C=CC=CC=1S(NC1=CC=CC2C(=C(C)C=CC=21)OC1C(=CC=CN=1)C1=CC=NC(=N1)N[C@@H]1CNCCC1)(=O)=O